PTC Therapeutics | PTCT - Ordinary Share Capital

Ptc Therapeutics reported $72K in Ordinary Share Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Alnylam Pharmaceuticals ALNY:US USD 1.24M 10K
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Cytokinetics CYTK:US USD 94K 1000
Daiichi Sankyo 4568:JP JPY 50B 0
Enanta Pharmaceuticals ENTA:US USD 209K 1000
Esperion Therapeutics ESPR:US USD 75K 3K
Intercept Pharmaceuticals ICPT:US USD 42K 1000
IONIS PHARMACEUT IONS:US USD 142K 0
Ironwood Pharmaceuticals IRWD:US USD 154K 1000
Novartis NOVN:VX USD 890M 0
Ptc Therapeutics PTCT:US USD 72K 1000
Puma Biotechnology PBYI:US USD 5K 0
Roche Holding ROG:VX 107M 0
Sangamo Biosciences SGMO:US USD 1.67M 49K
Sarepta Therapeutics SRPT:US USD 9K 0
Tg Therapeutics TGTX:US USD 146K 1000
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Xencor XNCR:US USD 601K 3K
YTE INCY:US USD 223K 1000